NuvOx Therapeutics, Inc.
NUOXDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
NanO2TM | Phase 2 | Glioblastoma Multiforme | - | - |
Frequently asked questions
What is in NuvOx Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in NuvOx Therapeutics, Inc.'s (NUOX) pipeline across Phase 2. Its lead program is NanO2TM (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is NuvOx Therapeutics, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for NuvOx Therapeutics, Inc. (NUOX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track NUOX biotech catalysts?→
Add NUOX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow NuvOx Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.